News >

Adjuvant CRT Linked to 83% Reduced Risk of Death in Endometrial Cancer

Jason Harris
Published: Friday, Sep 22, 2017

Pratibha S. Binder, MD

Pratibha S. Binder, MD
Women with node-positive stage IIIC endometrial cancer assigned to adjuvant chemoradiation therapy (CRT) had better survival than those assigned to chemotherapy or radiation therapy alone, according to results from a retrospective cohort study.

= 0.416).
Binder PS, Kuroki LM, Zhao P, et al. Benefit of combination chemotherapy and radiation stratified by grade of stage IIIC endometrial cancer [published online September 12, 2017]. Gynecol Oncol. doi: 10.1016/j.ygyno.2017.08.031.

... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication